Aida Šapčanin
About
In The Last Decade
Aida Šapčanin
27 papers receiving 431 citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 102
- Physiology 101
- Pharmacology 61
- Endocrine and Autonomic Systems 59
- Biochemistry 55
Countries citing papers authored by Aida Šapčanin
This map shows the geographic impact of Aida Šapčanin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aida Šapčanin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aida Šapčanin more than expected).
Fields of papers citing papers by Aida Šapčanin
This network shows the impact of papers produced by Aida Šapčanin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aida Šapčanin. The network helps show where Aida Šapčanin may publish in the future.
Co-authorship network of co-authors of Aida Šapčanin
This figure shows the co-authorship network connecting the top 25 collaborators of Aida Šapčanin. A scholar is included among the top collaborators of Aida Šapčanin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aida Šapčanin. Aida Šapčanin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 3 | |
| 6 | 6 | |
| 7 | 24 | |
| 8 | 7 | |
| 9 | 18 | |
| 10 | 45 | |
| 11 | 63 | |
| 12 | 9 | |
| 13 | 4 | |
| 14 | 2 | |
| 15 | 15 | |
| 16 | 23 | |
| 17 | 40 | |
| 18 | 39 | |
| 19 | 83 | |
| 20 | A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome. | 24 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.